Alphatec Stock Rises 126% as CEO Sells $2 Million in Stock – Here’s What Investors Need to Know

• Miles Patrick, CEO of Alphatec Holdings, sold 100,000 shares of the company’s stock for about $2.1 million, according to a recent Form 4 filing.

• This sale represented 1.82% of Miles Patrick’s direct holdings, reducing direct ownership to 5.14 million shares.

• The transfer only concerned direct participations, indirect interests remaining unchanged.

• These 10 stocks could be the next wave of millionaires ›

Miles Patrick, CEO of Alphatec Holdings (NASDAQ:ATEC)completed an open market sale of 100,000 shares on Monday for a total of $2.1 million, according to a recent report. Filing SEC Form 4.

Transaction value based on SEC Form 4 weighted average purchase price ($21.01); post-trade value based on Monday weighted average price ($21.01).

• How significant was the transaction in relation to Patrick’s historical business model?
  The sale of 100,000 shares matches the recent median size of open market transactions, indicating that this sale was typical for the period since November 2024 and was not unusually large or small for Patrick’s business.

• What impact did this transaction have on direct and overall insider ownership?
  The sale reduced Patrick’s direct holdings by 6.82%, leaving him with 5,135,398 shares held directly and maintaining substantial exposure, while indirect holdings through an IRA and LLC entity remain unchanged at 260,900 shares.

• Does the transaction reflect a change in pace or remaining marketable capacity?
  The steady pace of 100,000 shares over the past few months reflects a normalization of available holdings, with Patrick’s holdings having declined by around 20% over the past year, limiting the scale of additional disposals.

• How does the deal valuation compare to recent price action?
  The stock sold for around $21.01 per share, with the stock closing at $21.20 that day, up 126.3% from the previous 12 months, indicating that the transaction generated proceeds near current highs amid strong price momentum.

• Alphatec Holdings offers a full range of spine surgery devices, including neural monitoring systems, spine fixation platforms, interbody implants, biologics and patient positioning solutions.

• The Company generates revenue primarily through the sale of proprietary medical devices and related products to hospitals and surgical centers, distributed through a direct sales force and independent distributors in the United States.

• It is aimed at spine surgeons and healthcare providers specializing in the surgical treatment of spinal disorders, targeting both degenerative and complex pathologies.

Alphatec Holdings is an American medical device company focused on advancing surgical solutions for spinal disorders. Through continued innovation in device design and procedure integration, the company aims to improve patient outcomes and surgical efficiency in the spine market.

With a broad product portfolio and specialized sales network, Alphatec Holdings leverages its expertise to meet the evolving needs of spine surgeons and healthcare institutions, positioning itself as a technology leader in the medical device industry.

For long-term investors, insider sales only matter if they conflict with fundamentals or signal a change in conviction. In this case, neither appears to be true. Alphatec Holdings continues to build on a growth plan that has far outpaced the broader market, and this transaction fits perfectly into that context.

Operational momentum remains strong. In his most recent quarterAlphatec reported revenue of $197 million, up 30% year over year, with surgical revenue up 31% to $177 million. Meanwhile, adjusted EBITDA reached $26 million, increasing margins by more than 800 basis points. Management also raised its full-year guidance, projecting revenue of approximately $760 million and adjusted EBITDA of approximately $91 million, a substantial increase from previous expectations of $83 million and highlighting confidence in sustained demand across its spine portfolio.

It is also important to note that the sale itself was executed according to a pre-established Rule 10b5-1 plan and represented a modest reduction rather than a change in direction. Even after the transaction, the CEO retains more than 5.1 million shares directly owned, as well as additional indirect exposure, thereby preserving his economic alignment with shareholders. Ultimately, planned liquidity events like this don’t change the long-term thesis.

Sale on the open market: Sale of securities on a public stock exchange, accessible to any buyer at market prices.
SEC Form 4: A regulatory filing disclosing insider trading of a company’s securities by officers, directors, or significant shareholders.
Insider ownership: The percentage of a company’s stock owned by its officers, directors, or other insiders.
Direct participations: Stock owned personally by an individual, not through trusts or other entities.
Indirect participations: Stocks held through entities such as trusts, IRAs, or LLCs, not owned directly by the individual.
Arrangement: The act of selling or otherwise transferring ownership of an asset or security.
Weighted average price: The average price of shares sold, weighted by the number of shares at each price.
Cadence: The frequency or regularity with which transactions or activities occur over time.
Proprietary medical devices: Medical products designed, developed and owned exclusively by a specific company.
TTM: The 12-month period ending with the most recent quarterly report.
Spinal fixation platforms: Medical devices used to stabilize and support the spine during or after surgery.
Organic products: Products derived from living organisms used in medical treatments, for example to promote bone growth in surgery.

Have you ever felt like you missed the boat by buying the best performing stocks? Then you will want to hear this.

On rare occasions, our team of expert analysts issues a “Doubled” actions recommendation for businesses that they believe are on the verge of collapse. If you’re worried that you’ve already missed your chance to invest, now is the best time to buy before it’s too late. And the numbers speak for themselves:

• Nvidia: If you invested $1,000 when we doubled down in 2009, you would have $479,476!*

• Apple: If you invested $1,000 when we doubled down in 2008, you would have $49,342!*

• Netflix: If you invested $1,000 when we doubled down in 2004, you would have $482,451!*

Right now we’re issuing “Double Down” alerts for three incredible companiesavailable when you register Equity Advisorand there may not be another chance like this anytime soon.

See the 3 actions »

*Stock Advisor returns effective January 5, 2026

Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the securities mentioned. The Mad Motley has a disclosure policy.

Alphatec Stock Rises 126% as CEO Sells $2 Million in Stock – Here’s What Investors Need to Know was originally published by The Motley Fool